Brief: Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
06/08/2026 21:06
BRIEF-Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million Aug 06 (Reuters) - Relay Therapeutics Q2 operating income USD -90.824 million.
- Q2 revenue USD 350 thousand vs. IBES estimate USD 872.7 thousand
- Q2 operating expenses USD 91.174 million
- Q2 basic EPS USD -0.41
- Q2 EPS USD -0.41
Recent news on Relay Therapeutics
See all newsBrief: X-Chem Announces Phase 3 Milestone In Collaboration With Relay Therapeutics
Relay Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widens
Brief: Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
U.S. RESEARCH ROUNDUP- Alliant Energy, Prog Holdings, Travelers